Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Antibe Therapeutics Inc(Pre-Merger) ATBPF

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug, otenaproxesul, is in clinical development as an alternative to opioids and NSAIDs for acute pain. Its second pipeline drug, ATB-352, is being developed for a specialized pain indication. The Company also focuses on inflammatory bowel disease (IBD). Otenaproxesul combines a moiety that releases hydrogen sulfide with naproxen, a non-steroidal, anti-inflammatory drug. ATB-352 is an H2S-releasing derivative of ketoprofen, a potent NSAID commonly prescribed for acute pain. Its IBD candidates are being designed to maintain the efficacy, safety, and pharmacokinetic properties of ATB-429.


GREY:ATBPF - Post by User

Comment by MrMugsyon Apr 13, 2022 1:28pm
112 Views
Post# 34601025

RE:RE:RE:RE:Stutters thinks he's a performer ... hahaha

RE:RE:RE:RE:Stutters thinks he's a performer ... hahaha
StockingUp21 wrote:

Yes studder if you don't like losing 90% of what you invest muggys stock picks are not for you. 

fortune teller of how to lose fortunes



In all honesty Stockings ... I don't want you buying the stocks I buy.
You provide no insight - you have no patience - and you show no interest in these companies.
Your expectations are more in line with a dividend paying stock - yet - you've come to the wrong place and you want to complain about other people - rather than focus on your investments.

Kind of a gossip queen - you and stutters - actually.

How would you even go about explaining your purpose here ?

At least I'm consistent in the way I go about my business - did it with BPI Financial and they were acquired by CI, did it with IAM and they were acquired, did it with SVC and they were acquired, did it with DSA and they were acquired, did it with PHO and they were acquired, did it with PLB but didn't wait for the acquisition - will wait with GUD though, did it with PRN but didn't wait for the acquisition (will likely get back in).

My approach isn't for everyone - actually isn't for most - but that's OK, I'm not expecting others to do it my way.  My way is ultra-boring.

Do it your way - take ownership - enjoy the ride.

Being cranky just says you're a troll.

Be smart !

<< Previous
Bullboard Posts
Next >>